AlphaMaven AlphaMaven

Veritas Capital outbids CVC in £1.65bn Bodycote deal

Reported by Privateequitywire
Sep 2, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Veritas Capital has won the auction for Bodycote with a recommended offer of 940 pence per share in cash, valuing the UK-listed engineering specialist at approximately £1.65bn (£1.85bn enterprise value including debt).
  • • The winning bid represents an increase from both Veritas' and CVC Advisers' previous proposals, demonstrating competitive tension in the auction process.
  • • CVC Advisers has reserved the right to make a counter-offer and is advising shareholders to take no action, signaling the auction may not be conclusively closed.
  • • Bodycote shares traded above Veritas' offer price following the announcement, reflecting market expectations of a potential further bid; the stock has appreciated more than one-third year-to-date.
  • • Bodycote operates in specialized industrial services (heat treatment and surface coating for metal components), serving aerospace and other industrial sectors requiring high-performance materials.
Summary
US private equity firm Veritas Capital has secured a recommended offer to acquire Bodycote, the UK-listed engineering services specialist, at 940 pence per share in an all-cash transaction. The equity value stands at approximately £1.65bn, with total enterprise value reaching around £1.85bn when including assumed debt. According to Bloomberg, Veritas increased its offer to surpass rival bidder CVC Advisers in what remains an active competitive process.

The improved bid reflects escalating valuation pressure from multiple parties pursuing the asset. Both Veritas and CVC had previously submitted lower offers, which were rejected or matched in successive rounds. CVC has explicitly stated it is evaluating its options and has advised Bodycote shareholders to refrain from taking action, effectively reserving the right to submit a higher counter-proposal. This language signals the auction process is ongoing rather than concluded.

Market pricing suggests investors anticipate further bidding activity. Bodycote shares climbed as much as 4.4% on the announcement but have continued trading above Veritas' offer price, a technical indicator that shareholders are pricing in the possibility of an elevated counter-bid from CVC. The stock has gained approximately 33% since the start of 2026, suggesting either broader market strength or accumulating takeover expectations.

Bodycote provides heat treatment and surface coating services for metal components across industries including aerospace and defense. These specialized processes enhance component durability and resistance to extreme temperatures and mechanical wear—mission-critical properties in high-reliability industrial applications. The company's customer base and service lines position it as a valuable asset for a financial buyer seeking exposure to long-cycle aerospace and industrial end-markets.

Lazard is advising Veritas on the transaction. Bodycote's advisory team comprises Barclays, Goldman Sachs, Gleacher Shacklock, and Jefferies, representing a substantial roster consistent with managing a competitive auction environment. The deal remains subject to shareholder approval and regulatory clearance.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Privateequitywire Veritas Capital outbids CVC in £1.65bn Bodycote deal